Gefitinib vs Rosuvastatin

Gefitinib vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between Gefitinib and Rosuvastatin.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Rosuvastatin: Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics

Half-life: Gefitinib — 48 hours; Rosuvastatin — 19 hours.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3; Rosuvastatin — C22H28FN3O6S.

Molecular Weight: Gefitinib — 446.9000 g/mol; Rosuvastatin — 481.5390 g/mol.

Type: Gefitinib — Small molecule; Rosuvastatin — Small molecule.